methoxyhydroxyphenylglycol has been researched along with Chromosome Deletion in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abeling, N; Baas, F; Booij, J; Boot, E; de Haan, L; Linszen, D; van Amelsvoort, T; Zinkstok, J | 1 |
Berlin, F; Breakefield, XO; Eisenhofer, G; Ernst, M; George, T; Greenberg, BD; Murphy, DL; Sims, K; Zametkin, A | 1 |
2 other study(ies) available for methoxyhydroxyphenylglycol and Chromosome Deletion
Article | Year |
---|---|
Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome.
Topics: Adolescent; Adult; Amphetamine; Analysis of Variance; Case-Control Studies; Catechol O-Methyltransferase; Chromatography, High Pressure Liquid; Chromosome Deletion; Chromosomes, Human, Pair 22; Dopamine; Electrochemistry; Female; Genotype; Homovanillic Acid; Humans; Male; Mental Disorders; Methionine; Methoxyhydroxyphenylglycol; Neuropsychological Tests; Prolactin; Synaptic Transmission | 2008 |
Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?
Topics: Adolescent; Adult; Aged; Animals; Attention Deficit Disorder with Hyperactivity; Chromosome Deletion; Chromosome Mapping; Domestic Violence; Humans; Isoenzymes; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Reference Values; Risk Assessment; Selegiline; Sex Offenses; X Chromosome | 1998 |